A Randomized, Double-blind, Double-dummy, Placebo-controlled Study of Oral BGS649 Monotherapy Assessing Safety and Tolerability in Patients With Moderate to Severe Endometriosis.
Phase of Trial: Phase II
Latest Information Update: 11 Sep 2012
At a glance
- Drugs BGS 649 (Primary)
- Indications Endometriosis
- Focus Adverse reactions
- 06 Aug 2012 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
- 01 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Jul 2011 Planned end date changed from 1 Jul 2011 to 1 Sep 2011 as reported by ClinicalTrials.gov.